Skip to main content
. 2017 May 24;18(1):10–14. doi: 10.14744/AnatolJCardiol.2017.7170

Table 1.

Demographic characteristics and echocardiographic parameters of the lead-exposed and control groups

Characteristics Lead-exposed group (n=68) Control group (n=68) P
Age, year 34.7±8.1 34.1±9.4 0.690
Resting heart rate, bpm 76.3±10.6 73.4±9.7 0.098
Body mass index, kg/m2 24.7±3.6 23.6±3.8 0.085
Smoking, n (%) 29 (42.6) 22 (32.3) 0.217
Low-density lipoprotein, mg/dL 141.0±26.0 136.8±19.9 0.294
LV ejection fraction, % 64.5±3.7 64.5±3.1 0.980
End-diastolic diameter, mm 45.7±3.3 46.1±3.5 0.494
End-systolic diameter, mm 27.4±2.6 27.7±2.9 0.526
Left atrial diameter, mm 32.6±3.0 33.2±3.2 0.261
RV diameter, mm 25.1±2.4 25.8±2.7 0.112
sPAP, mm Hg 23.4±4.6 22.7±4.5 0.371
E wave, cm/s 74.5±18.6 80.1±19.8 0.093
A wave, cm/s 64.8±12.6 63.8±13.0 0.649
DT, ms 184.5±40.7 178.4±45.5 0.411
IVRT, ms 96.3±15.5 95.4±14.9 0.730
Working duration, months 45 [6 – 360]
Blood lead level, µg/dL 40.5 [11.4 – 90] 0.5 [0.1 – 0.8] <0.001
24-hour urine lead level, µg/L 34.9 [2.1 – 128] 0.1 [0.1 – 0.9] <0.001

DT - deceleration time; IVRT - isovolumic relaxation time; LV - left ventricle; RV - right ventricle; sPAP - systolic pulmonary arterial pressure. Numerical variables are expressed as mean±standard deviation or median (minimum–maximum)